Odence-Ford Marion - Insider Non-Derivative Transactions at OptimizeRx Corp (OPRX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Mar 1, 2024, Odence-Ford Marion's relationship to OptimizeRx Corp (OPRX) is Officer (General Counsel and CCO), and currently has 14,499 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other OPRX insiders.

Data Source: SEC.
Odence-Ford Marion - Insider Non-Derivative Transactions of OPRX Common Stock
Odence-Ford Marion - Insider Non-Derivative Transactions at OPRX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Mar 2, 2024 F -- (Common Stock) 268 15.95 14231
Mar 2, 2024 M -- (Common Stock) 771 0 14499
Feb 16, 2024 Acquisition -- (Common Stock) 4267 0 18498
Feb 12, 2024 F -- (Common Stock) 1386 15.39 13728
Feb 12, 2024 M -- (Common Stock) 4000 0 15114
Jan 10, 2024 Sell -- (Common Stock) 4000 15.19 11114
Nov 9, 2023 F -- (Common Stock) 524 9.21 15114
Nov 9, 2023 M -- (Common Stock) 1785 0 15638
Oct 4, 2023 F -- (Common Stock) 1952 7.06 13853
Oct 4, 2023 M -- (Common Stock) 6649 0 15805
Mar 2, 2023 F -- (Common Stock) 268 18.11 9156
Mar 2, 2023 M -- (Common Stock) 771 0 9424
Feb 12, 2023 F -- (Common Stock) 1422 17.34 8653
Feb 12, 2023 M -- (Common Stock) 4000 0 10075